Imricor Medical Systems, Inc. (Company or Imricor) (ASX: IMR), together with Amsterdam University Medical Centre (Amsterdam ...
A technique borrowed from radiation oncology that takes the catheter out of catheter ablation continued to put in an impressive performance, observers say, in the longest yet follow-up of patients ...
In a "strong statements and controversies" session at the European Heart Rhythm Association (EHRA) EUROPACE-CARDIOSTIM 2017 meeting, Prof Gerhard Hindricks (University of Leipzig, Germany) said ...
Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh ( (AU:IMR) ) just unveiled an announcement. Imricor Medical Systems, Inc. announced a significant milestone in the field of ...
Please provide your email address to receive an email when new articles are posted on . High-risk patients getting catheter ablation for ventricular tachycardia did not benefit from a mechanical ...
NEW ORLEANS – The Impella 5.0 and 5.5 left ventricular assist device failed to measure up on outcomes when used for high-risk patients undergoing ventricular tachycardia (VT) ablation therapies, ...
BERLIN, Germany—Performing ventricular tachycardia (VT) ablation before placement of a primary prevention implantable cardioverter-defibrillator (ICD) had a clinical benefit in a selected group of ...
In a finding that may improve the safety of an increasingly common procedure, use of direct oral anticoagulants (DOACs) instead of aspirin after radiofrequency ablation for ventricular tachycardia or ...
A percentage of patients with scar-related ventricular tachycardia who underwent radiofrequency catheter ablation experienced early mortality, which may have been predicted by procedural and clinical ...
WALTHAM, Mass.--(BUSINESS WIRE)--Thermedical ®, a developer of thermal-ablation medical systems to treat ventricular tachycardia (VT), today announced that it has received Breakthrough Device ...
WALTHAM, Mass.--(BUSINESS WIRE)--Thermedical ®, a developer of thermal-ablation systems to treat ventricular arrhythmias, announced today that the U.S. Food & Drug Administration (FDA) has approved an ...
Imricor Medical Systems, Inc. (Company or Imricor) (ASX: IMR), together with Amsterdam University Medical Centre (Amsterdam UMC), is pleased to announce the successful completion of the first Ischemic ...